Related Experiment Videos
Screening for skin-tumor promoters
1Department of Cell Biology and Cytogenetics, Japan Tobacco Inc., Kanagawa.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1988
Summary
The nitroblue tetrazolium (NBT) reduction test effectively screens for 12-0-tetradecanoylphorbol-13-acetate (TPA)-type skin tumor promoters. This method is comparable to existing techniques for identifying free radical-mediated carcinogens.
Area of Science:
- Oncology
- Biochemistry
- Toxicology
Background:
- Oxygen radicals are implicated in tumor promotion.
- Understanding the mechanisms of skin tumor promotion is crucial for developing preventative strategies.
Purpose of the Study:
- To evaluate the nitroblue tetrazolium (NBT) reduction test as a rapid screening method for skin tumor promoters.
- To determine if the NBT test is suitable for identifying 12-0-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters.
Main Methods:
- Utilized mouse peritoneal macrophages for the NBT reduction test.
- Assessed the NBT reduction capacity in response to potential tumor promoters.
Main Results:
- The NBT reduction test demonstrated utility in screening for TPA-type tumor promoters.
- The efficacy of the NBT test was comparable to other established screening methods for tumor promoters.
Conclusions:
- The NBT reduction test is an appropriate method for the rapid screening of TPA-type skin tumor promoters.
- This assay supports the understanding that many skin tumor promoters, including phorbol esters, teleocidin, and aplysiatoxin, may act via a free radical mechanism.